WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Vanda Pharmaceuticals earnings were -$84.2M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest VNDA earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$22.6M, down 17% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VNDA reported annual earnings of -$18.9M, with -853.3% growth.

VNDA earnings history

Current Revenue
$212.1M
Current Earnings
-$84.2M
Current Profit Margin
-39.7%

VNDA Return on Equity

Current Company
-16.8%
Current Industry
-7.5%
Current Market
33.7%
VNDA's Return on Equity (-16.8%)... subscribe to Premium to read more.
High Return on Equity Performance

VNDA undefined

Current Company
-13.4%
Current Industry
-5.5%
VNDA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VNDA announces earnings.

VNDA undefined

Current Company
-22.17%
Current Industry
0.9%
VNDA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VNDA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VNDA-$99.12M-$84.20MN/A-$1.43
EDIT-$195.18M-$199.84MN/A-$2.38
IMMP-$39.87M-$39.89MN/A-$0.27
ENTA-$82.41M-$92.01MN/A-$4.32
PBYI$50.16M$36.98M+134.06%$0.75
View Top Biotech Stocks

Vanda Pharmaceuticals Earnings Reports & History FAQ

What were Vanda Pharmaceuticals's earnings last quarter?

On VNDA's earnings call on Invalid Date, Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 2025 earnings per share (EPS) of -$0.38, up 322.22% year over year. Total VNDA earnings for the quarter were -$22.59 million. In the same quarter last year, Vanda Pharmaceuticals's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.

Is Vanda Pharmaceuticals profitable or losing money?

As of the last Vanda Pharmaceuticals earnings report, Vanda Pharmaceuticals is currently losing money. Vanda Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$84.20 million, a 413.78% increase year over year.

What was VNDA's earnings growth in the past year?

As of Vanda Pharmaceuticals's earnings date in Invalid Date, Vanda Pharmaceuticals's earnings has grown year over year. VNDA earnings in the past year totalled -$84.20 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.